Suicide attempt using potassium tablets for congenital chloride diarrhea: A case report

Abstract

BACKGROUND

Congenital chloride diarrhea (CCD) is a rare inherited disorder of intestinal electrolyte transport that results in a large wastage of electrolytes and water. Advances in substitution therapy using sodium chloride (NaCl) and potassium chloride (KCl) have dramatically improved survival for patients with CCD. Slow-release KCl is widely prescribed as a potassium supplement; however, it has also occasionally been used in suicide attempts, as potassium poisoning can generate life-threatening hyperkalemia.

CASE SUMMARY

A 26-year-old female presented to the emergency department (ED) with self-poisoning, having taken 30 tablets of slow-release KCl (total: 240 mmol potassium) following an auditory hallucination. The patient had been undergoing substitution therapy with NaCl and KCl for CCD and been followed up in the pediatric department. One month prior, she developed insomnia and anxiety and had consulted a psychiatrist. At the ED, although her general condition was good, she appeared agitated. Her serum potassium level was 7.0 mmol/L, indicating hyperkalemia, and electrocardiographic changes showed tenting of the T-waves. She responded to the administration of calcium gluconate, sodium bicarbonate, and insulin with glucose, and the serum potassium level improved. Finally, she was diagnosed with schizophrenia.

CONCLUSION

In CCD management, physicians should pay careful attention to patients’ extraintestinal issues, including psychological disorders that may emerge in adulthood.

Key Words: Congenital chloride diarrhea; Substitution therapy; Suicide; Potassium overdose; Schizophrenia; Case report

Core tip: The main treatment for congenital chloride diarrhea (CCD) is life-long substitution therapy using sodium chloride and potassium chloride. An oral potassium supplement overdose is rare but can cause life-threatening hyperkalemia in cases of intentional high-dosage ingestion. We encountered an adult patient with CCD who developed hyperkalemia due to self-poisoning of prescribed potassium chloride tablets. In patients with CCD, physicians need to consider extraintestinal issues that patients can encounter as they get older, along with the challenges they face concerning life-long diarrhea. It is especially important to be aware of any potential psychiatric disorders that may cause life-threatening sequelae.

INTRODUCTION

Congenital chloride diarrhea (CCD, OMIM 214700) is a rare autosomal recessive disease of impairment in intestinal Cl⁻/HCO₃⁻ exchange, due to mutations in the solute carrier family 26 member 3 (SLC26A3, OMIM 126650) gene, and is characterized by persistent, life-long, watery diarrhea with a high fecal chloride concentration (> 90 mmol/L)[1]. Worldwide, more than 250 cases of CCD have been reported[2]. Without treatment, most children die in infancy or survive with severely delayed psychomotor development. Advances in substitution therapy with sodium chloride (NaCl) and potassium chloride (KCl) have dramatically improved the survival of these patients, and the long-term prognosis of appropriately managed CCD has been reported to be favorable[3].

Although KCl is extensively used to supplement potassium as a therapeutic modality, potassium administration is also known to be a means in suicide/homicide attempts or in lethal procedures for state-sanctioned capital punishment. Potassium poisoning can cause life-threatening hyperkalemia, as harmful effects on the electric activity of the heart are the most important consequences of hyperkalemia. When serum potassium levels exceed 7 mmol/L, remarkable arrhythmic changes can be observed using electrocardiography. With serum potassium levels ≥ 8 mmol/L, sudden cardiac arrest can occur[4].

We encountered an adult patient with CCD who had attempted suicide through ingesting a large number of KCl tablets that had been prescribed for substitution therapy. No previous studies have focused on mental or psychiatric disorders involving patients with CCD, and no studies have reported the challenges facing patients with CCD related to life-long substitution therapy.

CASE PRESENTATION

Chief complaints

A 26-year-old female presented to the emergency department (ED) complaining of epigastric discomfort and nausea.

History of present illness

One month prior, the patient had developed insomnia and anxiety due to domestic difficulties. She consulted a psychiatrist and was prescribed anti-anxiety and hypnotic medications relevant to a diagnosis of adjustment disorders. On the day of the ED visit, she had experienced an auditory hallucination and had ingested 30 tablets of slow-release KCl (each tablet containing 8mmol potassium) in a suicide attempt. She then called her father because of the epigastric discomfort and nausea and he transported her to the ED four hours after ingestion.

History of past illness

At 16 months old, this patient was diagnosed with CCD based on hypochloremic alkalosis, hyponatremia, hypokalemia with increased plasma renin and aldosterone levels, and high fecal Cl⁻. In this case, because repeated sweat testing showed normal Cl⁻ concentration and because pulmonary illness did not develop during her clinical course, we are sure that the patient did not have cystic fibrosis. She has undergone substitution therapy with NaCl and KCl. On follow-up, watery diarrhea persisted, but she developed normally. In adulthood, she married and produced a healthy child after an uneventful pregnancy at the age of 24 years. Subsequently, the patient continued to visit the pediatric outpatient clinic four times a year. Her usual serum electrolyte concentrations were as follows: Na⁺: 140-143 mmol/L; K⁺: 2.8-3.4 mmol/L, and Cl⁻: 96-100 mmol/L, with a daily substitution of 48 mmol slow-release KCl. In this case, genetic diagnosis was considered; however, the patient did not approve of this diagnostic method and therefore, it was not performed.

Personal and family history

This patient was born with polyhydramnios at 36 wk gestation and weighing 2550 g. Both her parents are healthy but consanguineous. Her grandmother's brother died immediately after birth; however, the cause of death was unclear.

Physical examination

The patient was agitated, but her general condition was good. Her pulse rate was 105 beats/min and her blood pressure was 101/77 mmHg.

Laboratory examinations

Initial laboratory blood test results were as follows: pH: 7.419; partial pressure of carbon dioxide (CO₂): 30.8 mmHg; bicarbonate (HCO₃⁻): 20.0 mmol/L; base excess (BE): -5.0; Na⁺: 139 mmol/L; K⁺: 7.0 mmol/L; Cl⁻: 105 mmol/L; urea nitrogen: 7.3 mg/dL, and creatinine: 0.52 mg/dL.

Imaging examinations

Electrocardiographic changes of hyperkalemia were observed, with tenting of T-waves and smaller P-waves.

FINAL DIAGNOSIS

Hyperkalemia due to self-poisoning with slow-release KCl tablets in a suicide attempt.

TREATMENT

The hyperkalemia was treated with an intravenous injection of 8.5% calcium gluconate (20 mL) and 8.4% sodium bicarbonate (40 mL), and insulin with glucose infusion therapy (5 units of regular insulin (Humulin-R) and 20 g of glucose/hour) was started. The patient responded to treatment and, at six hours post-initiation of treatment, the serum potassium level had corrected to 4.0 mmol/L.

OUTCOME AND FOLLOW-UP

The patient was referred to the psychiatry department and was diagnosed with schizophrenia. She was subsequently admitted to an inpatient unit for treatment of her acute presentation with atypical antipsychotics (aripiprazole and risperidone), and she showed significant improvement. Concerning her present CCD management, the substitution therapy with slow-release KCl has been continued with very careful monitoring of this patient because of the lack of an alternative.

DISCUSSION

This is the first report focusing on mental or psychiatric disorders involving patients with CCD and the challenges facing these patients related to life-long substitution therapy. Despite persistent diarrhea, it has been reported that most patients with CCD appear to adjust to their condition and experience only minimal social disadvantage[5]. Moreover, ≥ 90% of patients with CCD are reported to consider their general health as excellent or good[3]. The patient presented in this report had acceptable growth, normal development, an uneventful pregnancy, and the delivery of a healthy child. Nevertheless, she had attempted suicide and was diagnosed with schizophrenia. The relationship between CCD and mental or psychiatric disorders remains unclear. Episodes of dehydration can result in mental and psychomotor impairment. In fact, this patient had often been hospitalized with dehydration due to acute gastroenteritis. In a clinical analysis of 21 Finnish patients with CCD published in 1977[6], one patient was reported to have had severe psychological difficulties, the details of which are not known, and the authors in that report indicated that those psychological issues were apparently unrelated to CCD. A recently published nationwide study in Japan reported that 23% of children with CCD had a neurodevelopmental or neuropsychiatric disorder in terms of their long-term outcomes[7]; however, the prevalence of various psychiatric disorders such as depression and schizophrenia in adult patients has not been reported. It is likely that long-term clinical outcomes have neither been captured nor recorded consistently in a standardized manner. Some patients with CCD have been reported to have developed inflammatory bowel disease (IBD)[2,8]. In IBD, psychiatric comorbidity is well recognized[9], and one recent study found a higher incidence of schizophrenia in an IBD cohort compared to controls[10]. Furthermore, an increased risk of a suicide attempt or ideation has been noted as a concern in patients with IBD[11]. Schizophrenia is a very common form of mental illness and its onset is significantly influenced through environmental factors or stressors[12]. One study showed that 30% of patients with schizophrenia had attempted suicide at least once during their lifetime[13]. A systematic review exploring suicide risk in patients with schizophrenia suggested that the risk factors leading to suicide appeared mainly related to stress[14]. In CCD, soiling remains common at all ages and, in adulthood, minor soiling has been reported to occur at night when sleeping or during physical exertion[3]. In addition to stress from persistent diarrhea, patients with CCD who appear socially adjusted may come under considerable physical or social stress after gaining independence from their parents and taking responsibility for their own lives. Following the critical childhood period, most patients with CCD visit the outpatient clinic only once or twice a year for routine examinations and prescriptions[3]. Moreover, most patients with CCD have previously only been followed by a pediatrician[4], who may not be able to recognize or address psychological problems unique to adulthood. Challenges facing adult patients with CCD, including mental health issues, should be investigated in detail, and psychological counseling may be required to improve a patient’s quality of life.

Regarding the therapeutic management of CCD, substitution using NaCl and KCl involves physiological changes and normally has no side-effects[5]. However, an overdose of KCl can generate severe hyperkalemia, leading to serious sequelae. Although poisoning events using drugs and chemicals are common, reports of potassium poisoning, especially in regard to oral self-poisoning, are rare. There are no large case series concerning potassium overdoses in the medical literature. An extensive medical literature search revealed only 13 case reports involving a total of 19 patients having had slow-release potassium poisoning (Table 1)[4,15-26]. Cases involving fatalities and survivors have both been reported. According to those case reports, even in previously healthy patients, ingestion of more than 20 tablets of slow-release potassium at once can cause severe hyperkalemia to develop over several hours, requiring intensive care. However, it takes a much smaller dose of ingested potassium to produce lethal toxicity in patients with compromised renal function than in those with normal renal function[19]. Although our patient had normal renal function, a relatively high incidence (28%) of chronic kidney disease was reported in a Finnish study of patients with CCD[2].

Table 1 Cases of suicidal poisonings associated with an oral intake of slow-release potassium chloride.

Ref.	Age/Sex	Underlying disease	Psychiatric disorder	Amount of K ingested	Time (h) from ingestion to arrival at ED	Peak serum K level (mmol/L)	Symptoms	ECG findings	Treatment	Outcome
Illingworth et al[15], 1980	36/M	Hypertension treated with thiazide diuretic	NR	Unknown	5	8.9	Vomoting	Wide QRS complex, hyperacute T-waves, short runs of ventricular tachycardia	Calcium gluconate, sodium bicarbonate, insulin/glucose, frusemide, ion exchange resin	Survived
Illingworth et al[15], 1980	58/F	Hypertension treated with thiazide diuretic	NR	20 T/168 mmol	5	9.1	Vomiting, sweating, breathlessness, cyanosis	Hyperacute T-waves, left bundle-branch block	Insulin/glucose, frusemide, gastric lavage, ion exchange resin	Survived
Illingworth et al[15], 1980	59/F	NR	NR	40 T/320 mmol	3.5	9.3	Vomit, cardiac arrest	Asystole	Gastric lavage	Died
Saxena[4], 1988	46/F	NR	Depression	100 T/800 mmol	1	9.6	Cardiac arrest	NR	Calcium gluconate, sodium bicarbonate, insulin/glucose, gastric lavage, activated charcoal, cathartic	Died
Steedma[16], 1988	27/F	Hypokalemia due to anorexia	Anorexia nervosa	60 T/480 mmol	12	9.1	Cyanosis, cold extremities, poor peripheral pulse	1st degree heart block, wide QRS complex, hyperacute T-waves	Calcium gluconate, sodium bicarbonate, insulin/glucose, ion exchange resin	Survived
Colledge et al[17], 1988	24/M	NR	NR	100 T/800 mmol	2	7.9	Vomiting	Hyperacute T-waves, sinus tachycardia, ventricular tachycardia	Calcium gluconate, sodium bicarbonate, insulin/glucose, gastric lavage, ion exchange resin	Survived
Peeters et al[18], 1998	62/F	NR	Depression	300 T/2400 mmol	NR	NR	Abdominal distention	NR	Endoscopic removal	Survived
Su et al[19], 2001	50/F	Hypertension	Anxiety disorder, depression	100 T/1000 mmol	1	9.7	Cramping abdominal pain, tachycardia	Hyperacute T-waves	Calcium chloride, sodium bicarbonate, insulin/glucose, gastric lavage, whole bowel irrigation, hemodialysis	Survived
	17/F	None	None	30 T/300 mmol	10	6.1	Nausea, vomiting, diarrhea	Tachycardia	Whole bowel irrigation	Survived
Wan et al[20], 2007	86/M	Hypertension treated with thiazide diuretic	Dementia	70 T/560 mmol	NR	6.8	Unknown	No feature of hyperkalemia	Calcium gluconate, sodium bicarbonate, insulin/glucose	Survived
Höjer et al[21], 2008	28/F1		Unknown disease with pacemaker in situ	Borderline personality disorder	100 C/1000 mmol	3	9.2	Cardiac arrest	Pacemaker capture	Calcium gluconate, sodium bicarbonate, insulin/glucose, gastric lavage, activated charcoal, ion exchange resin, hemodialysis	Survived
	28/F1	Unknown disease with pacemaker in situ	Borderline personality disorder	100 C/1000 mmol	1	6.9	Cardiac arrest	Pacemaker rhythm	Calcium gluconate, sodium bicarbonate, insulin/glucose, gastric lavage, activated charcoal, ion exchange resin	Survived
	28/F1	Unknown disease with pacemaker in situ	Borderline personality disorder	70 C/700 mmol	2.5	7.1	NR	Hyperacute T-waves	Sodium bicarbonate, insulin/glucose, ion exchange resin	Survived
Bosse et al[22], 2011	56/F	NR	Depression	60 T/480 mmol	5	11	Lethargy	Complex sine-wave rhythm	Calcium gluconate, sodium bicarbonate, insulin/glucose	Survived
Gunja[23], 2011	42/F2	NR	Bipolar disorder	40 T/320 mmol	1.5	5.5	NR	Sinus tachycardia, tall T-waves	Insulin, whole bowel irrigation	Survived
	42/F2	NR	Bipolar disorder	100 T/800 mmol	5	8.5	Tachycardia	Sinus tachycardia, tall T-waves	Calcium chloride, sodium bicarbonate, insulin, hemodialysis	Survived
Nilsson et al[24], 2012	30/F	NR	Depression	300 T/3000 mmol	5	10.3	Drowsiness, daze	Sine-wave tachycardia	Calcium gluconate, sodium bicarbonate, insulin/glucose, gastric lavage, ion exchange resin, hemodialysis, surgical removal	Survived
Guillermo et al[25], 2014	42/F	NR	Borderline personality disorder	100 T/800 mmol	2	3.9	Somnolence	Sinus tachycardia	Gastric lavage, activated charcoal, endoscopic removal	Survived
Briggs et al[26], 2014	44/F	Hypokalemia	Anxiety disorder	30 T/600 mmol	1.25	7.3	NR	Mildly peaked T-waves	Calcium gluconate, sodium bicarbonate, insulin/glucose, whole bowel irrigation, ion exchange resin, endoscopic removal	Survived

^1,2: Same patient, respectively; C: Capsule; ECG: Electrocardiogram; ED: Emergency department; F: Female; K: Potassium; M: Male; NR: Not reported; T: Tablet.

Therefore, when a patient with CCD develops a psychiatric disorder that may risk an attempt at suicide, other medication should be considered. However, therapeutic attempts to manage diarrhea using cholestyramine, omeprazole, and butyrate have not been as successful as hoped, suggesting that NaCl and KCl supplementation will continue to be more important than antidiarrheal therapy[1-3,7].

CONCLUSION

In patients with CCD, diarrhea is life-long and various extraintestinal issues may also emerge as patients become older unless an optimal radical therapy is established. Therefore, physicians need to pay careful attention not only to patients’ physical conditions but also to their mental health throughout their long-term follow-up, to ensure that any subsequent psychiatric disorders do not adversely affect CCD outcomes.